GREIL, Christine, ENGELHARDT, Monika, IHORST, Gabriele, SCHOELLER, Katja, BERTZ, Hartmut, MARKS, Reinhard, ZEISER, Robert, DUYSTER, Justus, EINSELE, Hermann, FINKE, Jürgen und WÄSCH, Ralph, 2019. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Freiburg: Universität.

Greil, C., Engelhardt, M., Ihorst, G., Schoeller, K., Bertz, H., Marks, R., Zeiser, R., Duyster, J., Einsele, H., Finke, J., Wäsch, R., 2019. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Universität, Freiburg. https://doi.org/10.3324/haematol.2018.200881

Greil, C., Engelhardt, M., Ihorst, G., Schoeller, K., Bertz, H., Marks, R., Zeiser, R., Duyster, J., Einsele, H., Finke, J., & Wäsch, R. (ca. 2019). Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life [Cd]. Universität. https://doi.org/10.3324/haematol.2018.200881

Greil C, Engelhardt M, Ihorst G, Schoeller K, Bertz H, Marks R, Zeiser R, Duyster J, Einsele H, Finke J, Wäsch R (2019) Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Universität, Freiburg

Greil, Christine/ Engelhardt, Monika/ Ihorst, Gabriele/ Schoeller, Katja/ Bertz, Hartmut/ Marks, Reinhard/ Zeiser, Robert/ Duyster, Justus/ Einsele, Hermann/ Finke, Jürgen/ Wäsch, Ralph, Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life, Freiburg 2019.